Difference between revisions of "EBoDE Data Overview"

From Testiwiki
Jump to: navigation, search
Line 221: Line 221:
 
| 2B
 
| 2B
 
|-  
 
|-  
−
|}
+
! rowspan="4" bgcolor="grey" | Ozone
−
 
+
| Total mortality (non-violent)
 +
| Adults (>30 yr)
 +
| rowspan="4" | Population <br> weighed ambient <br> SOMO35 level
 +
| µg m<sup>-3</sup>
 +
| RR
 +
| 1.0003
 +
| 1.0001
 +
| 1.000
 +
| WHO, 2006a
 +
|
 +
| 1A
 +
|-
 +
| Minor restricted activity days <br> (morbidity only)
 +
| Working age <br> (18–64 yr)
 +
| µg m<sup>-3</sup>
 +
| UR
 +
| 0.0115
 +
| 0.0044
 +
| 0.02
 +
| Hurley et al., 2005, WHO 2006b
 +
|
 +
| 2B
 +
|-
 +
| Cough days, children <br> (morbidity only)
 +
| School children <br> (5–14)
 +
| µg m<sup>-3</sup>
 +
| UR
 +
| 0.093
 +
| 0.019
 +
| 0.22
 +
| Hurley et al., 2005, WHO 2006b
 +
|
 +
| 2B
 +
|-
 +
| LRS days in children (excl cough) <br> (morbidity only)
 +
| School children <br> (5–14)
 +
| µg m<sup>-3</sup>
 +
| UR
 +
| 0.016
 +
| -0.043
 +
| 0.08
 +
| Hurley et al., 2005, WHO 2006b
 +
|
 +
| 2B
 +
|-
 +
! rowspan="4" bgcolor="grey" | PM<sub>2.5</sub>
 +
| Cardiopulmonary disease
 +
| Adults (>30 yr)
 +
| rowspan="4" | Population <br> weighted ambient <br> level
 +
| µg m<sup>-3</sup>
 +
| RR
 +
| 1.0077
 +
| 1.0020
 +
| 1.0132
 +
| Pope et al., 2002, WHO, 2006a
 +
|
 +
| 1A
 +
|-
 +
| Lung cancer
 +
| Adults (>30 yr)
 +
| µg m<sup>-3</sup>
 +
| RR
 +
| 1.012
 +
| 1.004
 +
| 1.020
 +
| Pope et al., 2002, WHO, 2006a
 +
|
 +
| 1A
 +
|-
 +
| Chronic bronchitis <br> (new cases)
 +
| Adults (>27 yr)
 +
| µg m<sup>-3</sup>
 +
| UR
 +
| 5.33 x 10<sup>-5</sup>
 +
| 1.70 x 10<sup>-6</sup>
 +
| 1.13 x 10<sup>-4</sup>
 +
| Hurley et al., 2005, WHO, 2006b
 +
|
 +
| 1A
 +
|-
 +
| Restricted activity days (RAD)
 +
| 15–64 yr
 +
| µg m<sup>-3</sup>
 +
| UR
 +
| 0.0902
 +
| 0.0792
 +
| 0.101
 +
| Hurley et al., 2005, WHO, 2006b
 +
|
 +
| 2B
 +
|-
 +
! bgcolor="grey" | Radon
 +
| Lung cancer
 +
| All
 +
| Residential mean <br> level
 +
| Bq m<sup>-3</sup>
 +
| RR
 +
| 1.0016
 +
| 1.0005
 +
| 1.0031
 +
| Darby et al. 2005
 +
|
 +
| 1A
 +
|}  
 +
 
===Table 2===
 
===Table 2===

Revision as of 06:38, 8 June 2011

Tables

Table 1

TABLE 3-19. Summary of health endpoints, exposure units and exposure/response-relationships. Unless otherwise stated, both mortality and morbidity were estimated.
Stressor Health endpoint Population Exposure estimate Unit of exposure Type of ERF Point estimate of ERFa) LCL (95%) UCL (95%) Reference(s) for ERF Threshold Calculation methodb)
Benzene Leukemia All Annual mean exposure µg m-3 UR 6.00 x 10-6 2.20 x 10-6 7.80 x 10-6 WHO, 2000a; IRIS 2003 2A
Dioxin Total cancer incidence All Daily intake of adults pg/kg/d UR 1.00 x 10-3 5.70 x 10-4 5.10 x 10-3 NAS, 2004, IRIS, 2006, Leino 2008 2A
SHS Tracheas, bronchus and lung cancers c) Adult non-smokers  % of people exposed (=yes) yes/no RR 1.21 1.13 1.30 US S.G., 2006 1A
Ischemic heart disease Adult non-smokers yes/no RR 1.27 1.19 1.36 US S.G., 2006 1A
Asthma induction Adult non-smokers yes/no RR 1.97 1.19 3.25 Jaakkola et al., 2003 1A
Asthma induction Children (<14 yr) parental
y/n 		RR 1.32 1.24 1.41 Cal-EPA, 2005 1A
Lower respiratory infections Infants (<2 yr) Parental
y/n 		RR 1.55 1.42 1.69 US S.G., 2006 1A
Otitis media Toddlers (<3 yr) Parental
y/n 		RR 1.38 1.21 1.56 Etzel et al., 1992; Cal-EPA 2005 1A
Formaldehyde Asthma aggravation (children)
(morbidity only) 		Toddlers (<3 yr) Annual mean residential indoor concentration µg m-3 RR 1.017 1.004 1.025 Rumchev et al., 2002 100 1A
Lead IQ loss Children (<5 yr) Distribution of blood lead levels µg/l UR 0.051 0.032 0.07 Landphear et al., 2005 24 2B
Mild mental retardation
(morbidity only) 		Children (<5 yr) µg/l DS d) function - - - 24 2B
Hypertensive diseases
(morbidity only) 		Adults/All µg/l DS d) function - - - 50 2B
Increased blood pressure Adults/All µg/l UR 2.50 x 10-2 1.70 x 10-2 3.20 x 10-2 Fewtrell et al. 2003, Schwartz, 1995 50 2B
Road traffic noise High sleep disturbance (HSD)
(morbidity only) 		All Persons exposed to predefined exposure categories Lnight (dB) UR function function function Miedema et al., 2007 2B
Ischemic heart disease (IHD) All Lday16h (dB) OR function function function Babisch, 2006 1A
Railway noise High sleep disturbance (HSD)
(morbidity only) 		All Lnight (dB) UR function function function Miedema et al., 2007 2B
Aircraft noise High sleep disturbance (HSD)
(morbidity only) 		All Lnight (dB) UR function function function Miedema et al., 2007 2B
Ozone Total mortality (non-violent) Adults (>30 yr) Population
weighed ambient
SOMO35 level 		µg m-3 RR 1.0003 1.0001 1.000 WHO, 2006a 1A
Minor restricted activity days
(morbidity only) 		Working age
(18–64 yr) 		µg m-3 UR 0.0115 0.0044 0.02 Hurley et al., 2005, WHO 2006b 2B
Cough days, children
(morbidity only) 		School children
(5–14) 		µg m-3 UR 0.093 0.019 0.22 Hurley et al., 2005, WHO 2006b 2B
LRS days in children (excl cough)
(morbidity only) 		School children
(5–14) 		µg m-3 UR 0.016 -0.043 0.08 Hurley et al., 2005, WHO 2006b 2B
PM2.5 Cardiopulmonary disease Adults (>30 yr) Population
weighted ambient
level 		µg m-3 RR 1.0077 1.0020 1.0132 Pope et al., 2002, WHO, 2006a 1A
Lung cancer Adults (>30 yr) µg m-3 RR 1.012 1.004 1.020 Pope et al., 2002, WHO, 2006a 1A
Chronic bronchitis
(new cases) 		Adults (>27 yr) µg m-3 UR 5.33 x 10-5 1.70 x 10-6 1.13 x 10-4 Hurley et al., 2005, WHO, 2006b 1A
Restricted activity days (RAD) 15–64 yr µg m-3 UR 0.0902 0.0792 0.101 Hurley et al., 2005, WHO, 2006b 2B
Radon Lung cancer All Residential mean
level 		Bq m-3 RR 1.0016 1.0005 1.0031 Darby et al. 2005 1A

Table 2

Retrieved from "http://www.opasnet.org/testiwiki/index.php?title=EBoDE_Data_Overview&oldid=21676"